Cardiff University | Prifysgol Caerdydd ORCA
Online Research @ Cardiff 
WelshClear Cookie - decide language by browser settings

Browse by Current Cardiff authors

Up a level
Export as [feed] Atom [feed] RSS 1.0 [feed] RSS 2.0
Number of items: 9.

Rees, Michael, Smith, Chris, Barrett-Lee, Peter and Hiscox, Steve 2020. PELP-1 regulates adverse responses to endocrine therapy in Estrogen Receptor (ER) positive breast cancer. Oncotarget 11 (51) , pp. 4722-4734. 10.18632/oncotarget.27846

Courtier, Nicholas, Gambling, Tina, Barrett-Lee, Peter and Mason, Malcolm D. 2018. Soluble interleukin-6 receptor mediated fatigue highlights immunological heterogeneity of patients with early breast cancer who undergo radiation therapy. Advances in Radiation Oncology 3 (4) , pp. 552-558. 10.1016/j.adro.2018.05.007

Bellerby, Rebecca, Smith, Chris, Kyme, Sue, Gee, Julia, Günthert, Ursula, Green, Andy, Rakha, Emad, Barrett-Lee, Peter and Hiscox, Stephen 2016. Overexpression of specific CD44 isoforms is associated with aggressive cell features in acquired endocrine resistance. Frontiers in Oncology 6 , 145. 10.3389/fonc.2016.00145

Gangadhara, Sharath, Smith, Chris, Barrett-Lee, Peter and Hiscox, Stephen 2016. 3D culture of Her2+ breast cancer cells promotes AKT to MAPK switching and a loss of therapeutic response. BMC Cancer 16 (1) , 345. 10.1186/s12885-016-2377-z

Gillespie, David, Hood, Kerenza, Farewell, Daniel, Hawthorne, Antony, Hurt, Chris Nicholas, Probert, Chris, Stenson, Rachel, Barrett-Lee, Peter, Casbard, Angela C. and Murray, Nick 2015. The use of randomisation-based efficacy estimators in non-inferiority trials [Poster Presentation]. Trials 16 (Suppl) , P129. 10.1186/1745-6215-16-S2-P129

Barrett-Lee, Peter, Casbard, Angela, Abraham, Jacinta, Hood, Kerenza, Coleman, Robert, Simmonds, Peter, Timmins, Hayley, Wheatley, Duncan, Grieve, Robert, Griffiths, Gareth and Murray, Nick 2014. Oral ibandronic acid versus intravenous zoledronic acid in treatment of bone metastases from breast cancer: a randomised, open label, non-inferiority phase 3 trial. Lancet Oncology 15 (1) , pp. 114-122. 10.1016/S1470-2045(13)70539-4

Nelson, Annmarie, Fenlon, Debbie, Morris, Jenny, Sampson, Catherine, Harrop, Emily, Murray, Nick, Wheatley, Duncan, Hood, Kerenza, Griffiths, Gareth and Barrett-Lee, Peter 2013. QUALZICE: A QUALitative exploration of the experiences of the participants from the ZICE clinical trial (metastatic breast cancer) receiving intravenous or oral bisphosphonates. Trials 14 (1) , 325. 10.1186/1745-6215-14-325

Welton, Joanne L., Marti, Salvador, Mahdi, Mohammed H., Boobier, Clare, Barrett-Lee, Peter and Eberl, Matthias 2013. γδ T cells predict outcome in zoledronate-treated breast cancer patients [Comment]. Oncologist 18 (8) , E22-E23. 10.1634/theoncologist.2013-0097

Dorak, M. Tevfik, McKinna, F., Schaaf, A., Machulla, H. K. G., Darke, C., Burnett, Alan Kenneth and Barrett-Lee, Peter 1996. Major histocompatibility complex and breast cancer. Human Immunology 49 (S 1) , pp. 11-22. 10.1016/S0198-8859(96)80042-5

This list was generated on Sat Sep 25 04:32:46 2021 BST.